Skip to main content
Fig. 3 | BMC Medical Imaging

Fig. 3

From: Differentiation of sarcoidosis-lymphoma syndrome lesions: a case report on the use of two different positron emission tomography tracers

Fig. 3

PET/CT images in a 54-year-old female with sarcoidosis–lymphoma syndrome after chemotherapy. Whole-body scan of FAMT PET/CT was performed at 60 min after 281.7 MBq of FAMT injection. (a-b FDG PET/CT; c-d. FAMT PET/CT). High FDG uptake in the mediastinal lymphadenopathies (red arrow) was still seen. The FDG–avid liver tumor lesions disappeared. No FAMT uptake that was compatible with sarcoidosis lesions was seen in the mediastinal lymphadenopathies (green arrow). FDG 18F-fluorodeoxyglucose, PET positive emission tomography, CT computed tomography, FAMT L–[3-18F] α-methyltyrosine

Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us